| |
|
|
|
TRACON Pharmaceuticals- Inc.  
|
|
2.65 -0.05 (-0.02%) |
07-13 16:00 |
|
Open: |
2.7 |
Pre close: |
2.7 |
Target:
|
3.43
|
|
High: |
2.7 |
Low: |
2.6 |
Resistance:
|
2.93
3.20
|
|
Volume: |
32,775 |
Market Cap: |
79M |
Support:
|
2.50
2.08
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.65
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
2.73 |
Signal(12,26,9): |
0.00 |
|
MA(100): |
2.62  |
Stochastic Oscillator |
%K(14,3):
|
29.86 |
|
MA(250): |
2.77 |
%D(3): |
24.03 |
|
Average Volume(K) |
3-Month: |
13184
|
52-Week |
High:
|
3.95 |
|
10-Days: |
5134 |
Low: |
2.00 |
|
RSI |
RSI(14):
|
48.09 |
Change(%): |
20.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.160 |
Return on Equity (ttm) |
-62.1 |
Shares Out. (M) |
29.73 |
|
EPS Est. Current Year |
-1.570 |
Return on Assets (ttm) |
-39.9 |
Shares Float (M) |
29.55 |
|
EPS Est. Next Year |
-1.830 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.60 |
|
EPS Est. Next Quarter |
-0.490 |
Qtrly Rev. Growth |
-100.0 |
% Held by Institutions |
58.50 |
|
Forward EPS |
-1.527 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
187 |
|
Book Value (p.s.) |
1.890 |
EBITDA (p.s.) |
-0.165 |
P/E |
-2.28 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.40 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.24 |
P/S |
151508656.00 |
|
Operating Margin |
-207.99 |
Levered Free Cash Flow
(M) |
-9.04 |
P/CF |
-5.95 |
|
|
|
|
|
|
